Document is current
Any future updates will be listed below
-
Authors
Fichtner, Alexander https://orcid.org/0000-0002-9939-4059
Gauché, Laura
Süsal, Caner https://orcid.org/0000-0003-2521-8201
Tran, Thuong Hien
Waldherr, Rüdiger
Krupka, Kai https://orcid.org/0000-0002-0409-5196
Guzzo, Isabella https://orcid.org/0000-0003-4960-3083
Carraro, Andrea https://orcid.org/0000-0001-9564-9491
Oh, Jun
Zirngibl, Matthias https://orcid.org/0000-0003-3661-6176
Weitz, Marcus https://orcid.org/0000-0002-1696-5646
König, Jens https://orcid.org/0000-0002-9732-8656
Büscher, Anja
Berta, Laszlo https://orcid.org/0000-0002-9388-0670
Simon, Thomas https://orcid.org/0000-0002-0651-7786
Awan, Atif https://orcid.org/0000-0002-1615-2602
Rusai, Krisztina https://orcid.org/0000-0003-2667-7389
Topaloglu, Rezan
Peruzzi, Licia https://orcid.org/0000-0002-5704-3867
Printza, Nikoleta https://orcid.org/0000-0003-1618-9285
Kim, Jon Jin
Weber, Lutz T. https://orcid.org/0000-0003-4116-598X
Melk, Anette
Pape, Lars
Rieger, Susanne
Patry, Christian
Höcker, Britta https://orcid.org/0000-0003-4131-2273
Tönshoff, Burkhard https://orcid.org/0000-0002-6598-6910
,
-
Funding
Funding for this research was provided by:
H2020 European Research Council (grant no. 952512)
Medizinische Fakultät Heidelberg der Universität Heidelberg
- License Information
-
More Information
Article History
Received: 5 March 2024
Revised: 26 July 2024
Accepted: 26 July 2024
First Online: 16 September 2024
Declarations
:
: Alexander Fichtner has received travel grants from Astellas and Novartis. Licia Peruzzi has received consulting fees from Alexion. Lutz T. Weber has received a research grant from Chiesi. Britta Höcker has received consulting fees from GlaxoSmithKline. Burkhard Tönshoff has received research grants from Novartis, Astellas, and Chiesi, and consulting fees from Bristol-Myers Squibb, CSL Behring Biotherapies for Life, Vifor, and Chiesi. The other authors declare no conflicts of interest.
